Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Log out
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Editorials

Fetal Programming of Type 2 Diabetes

Is sex important?

  1. Chittaranjan S. Yajnik, MD, FRCP,
  2. Koumudi Godbole, MD, FCCMG,
  3. Suhas R. Otiv, MD and
  4. Himangi G. Lubree, MSC
  1. From the Kamalnayan Bajaj Diabetology Research Centre, KEM Hospital and Research Centre, Pune, India
  1. Address correspondence to Dr. Chittaranjan Sakerlal Yajnik, KEM Hospital and Research Center, 6th Floor, Banoo Coyaji Building, Sardar Mudliar Road, Rasta Peth, Pune 411011, India. E-mail: diabetes{at}vsnl.com
Diabetes Care 2007 Oct; 30(10): 2754-2755. https://doi.org/10.2337/dc07-1485
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

Is sex important?

Hales and Barker (1) caused a paradigm shift in our thinking about diabetes prevention when they demonstrated that low birth weight (due to growth retardation) predicted type 2 diabetes (the “thrifty phenotype” or “fetal origins” hypothesis). On the other hand, larger babies of diabetic mothers are also at higher risk of diabetes, apart from their genetic susceptibility (“fuel mediated teratogenesis”) (2,3). A concept evolved that the intrauterine experiences mold the fetal systems (“programming”) and influence future health (4). If the postnatal experiences are at variance with the intrauterine ones, the programmed fetus is susceptible to disease (5). For example, low birth weight babies who put on excess weight in later life are at a higher risk of type 2 diabetes than those who continue to be low weight (6). In the programming hypothesis, the focus is on the role of intrauterine environment and on gene-environment interaction rather than the differences in gene structure, which are the basis of conventional genetics. Genes are clearly important, and their role in intrauterine development and risk of diabetes was highlighted by Hattersley and Tooke (the “fetal insulin hypothesis”) (7). The most exciting thought in fetal programming is that intrauterine environment may modify gene expression permanently. A heritable change in gene expression without a change in DNA sequence is called “epigenetic” (8), a term first used by Waddington in developmental biology. Epigenetic changes alter gene function and can be silencing or activating. These changes are inherited mitotically in somatic cells, which could explain long-term effects on gene expression in an organism, contributing to phenotypic diversity. They might also be inherited transgenerationally, affecting the health of future generations. Silencing of one of the two X chromosomes in females is an example of epigenetic change, and clinicians may also be familiar with Prader Willi syndrome, caused by disordered genomic imprinting. During intrauterine life, there are waves of epigenomic modification, intimately associated with growth and development, and opportunities galore for environmental factors to influence these processes. A fetus thus programmed travels a path of limited options.

Today we have only a preliminary knowledge of mechanisms of epigenetic regulation. Various enzymatic modifications affect gene function, including methylation of cytosine residues at CpG dinucleotides in DNA molecule and acetylation of specific lysine residues in the histones that package the DNA, both leading to an alteration in the transcription profile. These patterns of chemical modification are mitotically transmitted and therefore become permanent for the cell line. Methylation is influenced by the availability of 1-C (methyl) donors (vitamin B12, folate, choline, betaine, etc). Animal experiments provided the much-needed molecular proof of nutritional programming: Pregnant viable yellow Agouti mice (a genetically obese mouse) fed a “methylating cocktail” gave birth to offspring who showed a spectrum of coat color and were less obese despite inheriting the mutation. This was a result of increased methylation in the promoter region of the Agouti gene (9,10). In the Pune Maternal Nutrition Study, we found that high maternal homocysteine concentrations predicted fetal growth restriction (11) and that low maternal vitamin B12 and high folate nutrition predicted adiposity and insulin resistance in children at 6 years of age (12), suggesting nutritional programming. Intrauterine life thus provides a window of opportunity to influence the health of an individual. Studies in maternal fetal medicine and cord blood measurements will provide useful clues.

Shields et al. (13) make a welcome contribution to this process by reporting two interesting observations in the Exeter Family Study of Childhood Health. They found that EDTA anticoagulant and refrigeration preserve cord blood insulins for up to 48 h after collection, providing a useful guideline for researchers. The exciting observation is that girls had 15–25% higher concentrations of cord insulin compared with those in boys, independent of the many confounders (maternal size and glycemia in late pregnancy, length of gestation, mode of delivery, and glucose concentration in the cord blood). They claim that girls are “intrinsically” more insulin resistant than boys. The situation is analogous to the finding that cord insulin concentrations are higher in South Asian Indian compared with Caucasian babies (14). It's interesting that in both the situations, the smaller hyperinsulinemic babies have a smaller lean mass but higher body fat (adiposity).

This paper raises important issues: Are females more insulin resistant or only hyperinsulinemic? Is this an intrinsic characteristic, and if so, is it genetic or epigenetic? What is the role of hormones? A sex difference also exists in the cord blood concentrations of growth hormone, IGFs, leptin, and sex hormones.

Insulin has both metabolic and growth-promoting actions. Higher insulin concentrations but similar glucose and smaller body size could indicate higher insulin resistance in girls. This reasoning reflects the well-known principle of feedback regulation in endocrinology exemplified in the homeostatis model assessment (15). The caveats for such an interpretation in cord blood are as follows: the feedback system is not fully mature at birth, and parturition is not a steady-state situation. Thus, the interpretation of insulin resistance should be considered provisional and await direct measurements by clamp studies, which are technically demanding and ethically challenging. Measurement of other markers of insulin resistance (adiponectin, resistin, retinol binding protein 4, etc.) is likely to provide extra information. Another possible explanation for this observation could be that girls may have increased B-cell sensitivity of insulin secretion to circulating glucose and other nutrients (16).

Hyperinsulinemia at birth (unaffected by lifestyle) may suggest that it's intrinsic to female sex. This is the basis of the “sex insulin hypothesis” (17). Does this mean that it is genetic? Females have two copies of the X chromosome, one of which is inactivated soon after fertilization (imprinting), though some 15% of genes escape and produce a double-dose effect. Insulin-resistant diabetes is common in both Turner syndrome (monosomy X) (18,19) and in Klinefelter syndrome/variants (polysomy X) (20,21). Intriguingly, in the majority of Turner syndrome cases the deleted X chromosome is paternal, and in Klinefelter syndrome cases the extra X chromosome is mostly maternal, suggesting a possible link between maternal X chromosome, insulin resistance, and diabetes. In addition, some autosomal genes are also imprinted in females, including some that control glucose and fatty acid metabolism (22). On the other hand, cord insulin concentrations are also influenced by paternal insulin resistance (23), and children of diabetic fathers have a lower birth weight, suggesting a paternal influence on fetal insulin resistance (24). Matters are further complicated by hormones; for example, women are more insulin resistant during prepubertal and postmenopausal years, whereas men seem to be more insulin resistant during reproductive years (25).

Most of the recent excitements in genetics of type 2 diabetes are related to Β-cell function. Investigations into genetics and epigenetics of sex insulin difference could shed more light on the origins of insulin resistance. Future studies should include maternal metabolic, nutritional, and other factors; a standardized protocol to assess fetal growth; and cord blood and placental tissue collection to investigate genetic and epigenetic factors. Analysis of previous datasets by sex difference and parent-of-origin effect are likely to provide valuable information.

Acknowledgments

We thank Pranav Yajnik for his invaluable contribution to this editorial.

Footnotes

  • DIABETES CARE

References

  1. ↵
    Hales CN, Barker DJ: Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35:595–601, 1992
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    Pettitt DJ, Aleck KA, Baird HR, Carraher MJ, Bennett PH, and Knowler WC: Congenital susceptibility to NIDDM: role of intrauterine environment. Diabetes 37:622–628, 1988
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Freinkel N: Of pregnancy and progeny. Diabetes 29:1023–1035, 1980
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Lucas A: Programming by early nutrition in man. In The Childhood Environment and Adult Disease. Bock GR, Whelan J, Eds. Chichester, U.K., Wiley, 1991, p. 38–55
  5. ↵
    Gluckman PD, Hanson MA: Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Pediatr Res 56:311–317, 2004
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    Bavdekar A, Yajnik CS, Fall CHD, Bapat S, Pandit AN, Deshpande V, Bhave S, Kellingray SD, Joglekar CV: Insulin resistance in 8 year old Indian children: small at birth, big at 8 years, or both? Diabetes 48:2422–2429, 1999
    OpenUrlAbstract
  7. ↵
    Hattersley AT, Tooke JE: The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 353:1789–1792, 1999
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    Jirtle RL, Skinner MK: Environmental epigenomics and disease susceptibility. Nat Rev Genet 8:253–262, 2007
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    Cooney CA, Dave AA, Wolff GL: Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr 132:2393S–2400S, 2000
    OpenUrl
  10. ↵
    Waterland RA, Jirtle RL: Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23:5293–5300, 2003
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Yajnik CS, Deshpande SS, Panchanadikar AV, Naik SS, Deshpande JA, Coyaji KJ, Fall C, Refsum H: Maternal total homocysteine concentration and neonatal size in India. Asia Pac J Clin Nutr14:179–81, 2005
    OpenUrl
  12. ↵
    Yajnik CS, Deshpande SS, Jackson AA, Refsum H, Rao S, Fisher D, Bhat DS, Naik SS, Coyaji KJ, Joglekar CV, Joshi N, Lubree HG, Deshpande VU, Rege SDS, Fall CHD: Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia. In press
  13. ↵
    Shields BM, Knight B, Hopper H, Hill A, Powell RJ, Hattersley AT, Clark PM: Measurement of cord insulin and insulin-related peptides suggests that girls are more insulin resistant than boys at birth. Diabetes Care 30:2661–2666, 2007
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Yajnik CS, Lubree HG, Rege SS, Naik SS, Deshpande JA, Deshpande SS, Joglekar CV, Yudkin JS: Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocrinol Metab 87:5575–5580, 2002
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419, 1985
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    Hockaday D, Sayyad M, Yajnik C: Appreciating homeostasis model assessment: more useful earlier rather than later. Diabetes Care 30:2414–2418, 2007
    OpenUrlFREE Full Text
  17. ↵
    Wilkin TJ, Murphy MJ: The gender insulin hypothesis: why girls are born lighter than boys, and the implications for insulin resistance. Int J Obes 30:1056–1061, 2006
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    Salgin B, Amin R, Yuen K, Williams RM, Murgatroyd P, Dunger DB: Insulin resistance is an intrinsic defect independent of fat mass in women with Turner's syndrome. Horm Res 65:69–75, 2006
    OpenUrlCrossRefPubMed
  19. ↵
    Caprio S, Boulware S, Diamond M, Sherwin RS, Carpenter TO, Rubin K, Amiel S, Press M, Tamborlane WV: Insulin resistance: an early metabolic defect of Turner's syndrome. J Clin Endocrinol Metab 72:832–836, 1991
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    Nielsen J, Johansen K, Yde H: Frequency of diabetes mellitus in patients with Klinefelter's syndrome of different chromosome constitutions and the XYY syndrome: plasma insulin and growth hormone level after a glucose load. J Clin Endocrinol Metab 29:1062–1073, 1969
    OpenUrlCrossRefPubMed
  21. ↵
    Yesilova Z, Oktenli C, Sanisoglu SY, Musabak U, Cakir E, Ozata M, Dagalp K: Evaluation of insulin sensitivity in patients with Klinefelter's syndrome: a hyperinsulinemic euglycemic clamp study. Endocrine 27:11–15, 2005
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    Kiens B, Roepstorff C, Glatz JF, Bonen A, Schjerling P, Knudsen J, Nielsen JN: Lipid-binding proteins and lipoprotein lipase activity in human skeletal muscle: influence of physical activity and gender. J Appl Physiol 97:1209–1218, 2004
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Shields BM, Knight B, Turner M, Wilkins-Wall B, Shakespeare L, Powell RJ, Hannemann M, Clark PM, Yajnik CS, Hattersley AT: Paternal insulin resistance and its association with umbilical cord insulin concentrations. Diabetologia 49:2668–2674, 2006
    OpenUrlCrossRefPubMed
  24. ↵
    Lindsay RS, Dabelea D, Roumain J, Hanson RL, Bennett PH, Knowler WC: Type 2 diabetes and low birth weight: the role of paternal inheritance in the association of low birth weight and diabetes. Diabetes 49:445–449, 2000
    OpenUrlAbstract
  25. ↵
    Mittendorfer B: Insulin resistance: sex matters. Curr Opin Clin Nutr Metab Care 8:367–372, 2005
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Diabetes Care: 30 (10)

In this Issue

October 2007, 30(10)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Fetal Programming of Type 2 Diabetes
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Fetal Programming of Type 2 Diabetes
Chittaranjan S. Yajnik, Koumudi Godbole, Suhas R. Otiv, Himangi G. Lubree
Diabetes Care Oct 2007, 30 (10) 2754-2755; DOI: 10.2337/dc07-1485

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Fetal Programming of Type 2 Diabetes
Chittaranjan S. Yajnik, Koumudi Godbole, Suhas R. Otiv, Himangi G. Lubree
Diabetes Care Oct 2007, 30 (10) 2754-2755; DOI: 10.2337/dc07-1485
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Acknowledgments
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Strategies to Reduce the Cost of Renal Complications in Patients With Type 2 Diabetes
  • Metformin Therapy During Pregnancy
  • Postprandial Glucose: Marker or Risk Factor?
Show more Editorials

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.